Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Inv. presentation
Consulting agrmnt
|
|
Anixa Biosciences Inc (ANIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Gottschalk Emily (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 01/04/2023 |
4
| Catelani Michael (President, COO & CFO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 350,000 options to buy
@ $4.19, valued at
$1.5M
|
|
| 01/04/2023 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 01/04/2023 |
4
| Baskies Arnold M (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 01/04/2023 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 700,000 options to buy
@ $4.19, valued at
$2.9M
|
|
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Paid exercise price by delivering 491,900 shares
@ $4.48, valued at
$2.2M
Exercised 640,000 options to buy
@ $2.575, valued at
$1.6M
|
|
| 09/16/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Gifted 300,000 shares
@ $0 |
|
| 06/28/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Exercised 30,000 options to buy
@ $2.575, valued at
$77.3k
Exercised 16,000 options to buy
@ $2.575, valued at
$41.2k
|
|
| 05/02/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Acquired 1,086 shares
@ $2.76, valued at
$3k
|
|
| 04/27/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 10,000 shares
@ $2.79, valued at
$27.9k
|
|
| 04/22/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 5,500 shares
@ $2.66, valued at
$14.6k
|
|
| 04/21/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 2,509 shares
@ $2.53, valued at
$6.3k
|
|
| 04/15/2022 |
4
| Catelani Michael (President) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 100,000 options to buy
@ $2.62, valued at
$262k
|
|
| 03/11/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 100,000 options to buy
@ $2.74, valued at
$274k
|
|
| 03/11/2022 |
4
| Catelani Michael (COO & CFO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 500,000 options to buy
@ $2.74, valued at
$1.4M
|
|
| 03/11/2022 |
4
| Gottschalk Emily (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 100,000 options to buy
@ $2.74, valued at
$274k
|
|
| 03/11/2022 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 500,000 options to buy
@ $2.74, valued at
$1.4M
|
|
| 03/11/2022 |
4
| Baskies Arnold M (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Granted 100,000 options to buy
@ $2.74, valued at
$274k
|
|
| 01/13/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 5,000 shares
@ $3.28, valued at
$16.4k
|
|
| 01/12/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 2,000 shares
@ $3.2, valued at
$6.4k
|
|
| 01/11/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 6,000 shares
@ $3.08, valued at
$18.5k
|
|
| 01/10/2022 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 11,000 shares
@ $3.08, valued at
$33.9k
|
|
| 01/07/2022 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 20,000 shares
@ $3, valued at
$60k
|
|
| 11/02/2021 |
4
| Catelani Michael (COO & CFO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Acquired 743 shares
@ $4.04, valued at
$3k
|
|
| 11/01/2021 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 18,244 shares
@ $4.76, valued at
$86.8k
|
|
| 11/01/2021 |
4
| KUMAR AMIT (CEO) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 2,000 shares
@ $4.77, valued at
$9.5k
|
|
| 07/28/2021 |
4
| Titterton Lewis H jr (Director) has filed a Form 4 on Anixa Biosciences Inc|
Txns:
| Bought 30,000 shares
@ $4.21, valued at
$126.3k
|
|
|
|
|